In PNAS this week: genetic diversity of MERS in African camels, centromere evolution in Cryptococcus, and more.
The companies will offer a system for the identification and quantitation of metabolites in biological samples.
In PLOS this week: metabolite profiles of typhoid fever, shifts in cell-free DNA levels following exercise, and more.
The researchers found multiple enzymes that indicate causes of dysregulated adaptive immunity and tissue damage in fatal Ebola virus disease.
Bioage Labs now intends to set up an internal laboratory to experiment with different compounds, while building out its team.
In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.
Investigators are searching for non-invasive biomarkers of rejection and earlier stage graft injury in children and adults who have received kidney transplants.
Researchers reported on results for more than 100 healthy individuals who were tracked with 'omics and clinical tests over nine months.
The consortium is collecting data from different omics streams for a cohort of individuals with autism spectrum disorders with the long-term goal of improving treatment.
The firm has settled on a set of metabolite biomarkers, along with an algorithm, for its first version of a test for arterial plaque buildup.
23andMe and Airbnb have partnered to offer "heritage travel," according to Venture Beat.
China may include regulations protecting genes and embryos in its update of its civil code, Nature News reports.
In Nature this week: exome sequence analysis of individuals with type 2 diabetes, genomic prediction of maize yield across environments, and more.
NPR reports on efforts to engineer bacteriophages to destroy antibiotic-resistance bacteria.